Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Anticoccidial Drugs Market?

In recent times, the market size for anticoccidial drugs has seen robust growth. There is a projection that it will upscale from $1.27 billion in 2024 to $1.35 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.6%. The past expansion is linked to a worldwide spike in coccidiosis cases, greater acceptance of pet animals, high occurrences of coccidiosis, economic influences, and heightened worry over food and animal health safety.

The market for anticoccidial drugs is set to witness robust expansion over the coming years, with projections estimating a surge to “$1.75 billion by 2029,” marking an annual growth rate of 6.5%. This expected growth during the forecast period is credited to various factors including an increase in veterinary healthcare, the growing incidence of coccidiosis in animals, escalated use of synthetic drugs, rising demand for feed additives, and an uptick in livestock production. Trends for the forecast period signal a boost in demand due to new coccidiosis strains, a tilt towards organic and alternate treatment approaches, amplified regulatory scrutiny stimulating innovative practices, growing consumer inclination towards poultry products free of antibiotics, advances in drug delivery methods, enhanced emphasis on preventive healthcare initiatives, and widened use in aquaculture and pet animal sectors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

What Drivers Are Accelerating Expansion Of The Anticoccidial Drugs Market?

The expansion of the anticoccidial drug market is projected to be fuelled by the surge in meat protein demand. These proteins, found naturally in animal flesh, consist of numerous vital amino acids necessary for various bodily functioning. Population rise, enhanced disposable income, urban growth, and a shift in dietary choices towards protein-dense food are all contributing to the uptick in meat protein demand. Anticoccidial drugs play a significant role in today’s livestock farming, helping maintain animal health and productivity and enabling farmers to fulfil the increasing meat protein demand effectively and sustainably. For example, a report released in July 2023 by the France-based Organization for Economic Co-operation and Development (OECD) and Italy’s specialized Food and Agriculture Organization agency revealed that despite a predicted 2% rise in global average per capita meat demand between 2020-2022 and 2032, the FAO meat price index escalated by 10% in 2022 due to depleted export supplies. Thus, the rising demand for meat proteins is propelling the growth of the anticoccidial drug market.

What Are The Primary Segmentation Parameters In The Anticoccidial Drugs Market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Which Emerging Trends Are Reshaping The Anticoccidial Drugs Market Landscape?

Primary players in the anticoccidial drugs market, like Zoetis, are concentrating their efforts on creating novel products such as synthetic coccidiostats. The aim is to augment efficacy, curb the occurrence of resistance, and tackle new issues in poultry and livestock care. Synthetic coccidiostats are specially made compounds that deter or manage coccidiosis by impeding the growth and reproduction of coccidia parasites in animals. For instance, Zoetis, an animal health company based in the US, released Avi-Deccox in March 2023. This newly reformulated synthetic coccidiostat is engineered to control coccidiosis in broiler chickens, specifically targeting the pathogens Eimeria acervulina and Eimeria tenella, associated with major financial setbacks in poultry farming. Just like its predecessor, Deccox, the primary active component in Avi-Deccox is decoquinate. By utilising a different action mode, Avi-Deccox offers a more effective short-term resolution to the increasing problem of resistance associated with the prevalent use of ionophores in poultry farming.

Who Are The Dominant Players In The Anticoccidial Drugs Market Today?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What Are The Emerging Regional Trends Driving The Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model